SGRY logo

Surgery Partners, Inc. Stock Price

NasdaqGS:SGRY Community·US$2.1b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

SGRY Share Price Performance

US$0
-22.47 (-100.00%)
US$17.95
Fair Value
US$0
-22.47 (-100.00%)
Price US$0

SGRY Community Narratives

·
Fair Value US$17.95 15.8% undervalued intrinsic discount

Outpatient Shifts And CMS Changes Will Expand Surgical Potential

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
·
Fair Value US$23.49 35.6% undervalued intrinsic discount

Aging Population And Minimally Invasive Advances Will Fuel Outpatient Demand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$14 8.0% overvalued intrinsic discount

Leverage And CMS Shifts Will Curb Earnings Yet Spark Recovery

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$17.95
15.8% undervalued intrinsic discount
Profit Margin
1.84%
Future PE
44.35x
Price in 2029
US$23.67

Trending Discussion

Updated Narratives

SGRY logo

SGRY: Q1 Execution And 2026 Outlook Will Support Margin Recovery

Fair Value: US$23.49 35.6% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SGRY logo

SGRY: Reset Expectations And Steady Guidance Will Shape Future Multiple Potential

Fair Value: US$14 8.0% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SGRY logo

SGRY: Margin Repair And Payer Mix Reset Will Support 2026 EBITDA Recovery

Fair Value: US$17.95 15.8% undervalued intrinsic discount
4 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with adequate balance sheet.

0 Risks
3 Rewards

Surgery Partners, Inc. Key Details

US$3.3b

Revenue

US$2.6b

Cost of Revenue

US$763.3m

Gross Profit

US$839.4m

Other Expenses

-US$76.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.59
22.83%
-2.28%
80.4%
View Full Analysis

About SGRY

Founded
2004
Employees
16000
CEO
J. Evans
WebsiteView website
www.surgerypartners.com

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Recent SGRY News & Updates

Narrative Update Jun 30

SGRY: Q1 Execution And 2026 Outlook Will Support Margin Recovery

Analysts have revised their fair value estimate for Surgery Partners from $25.00 to about $23.49, citing updated assessments of discount rates, revenue growth, profit margins, and future P/E assumptions based on recent research. Analyst Commentary Recent Street research around Surgery Partners highlights a mix of adjustments to price targets, with some bullish analysts focusing on the company’s capacity to execute on its plans while reassessing risk and return assumptions.
Analysis Article Jun 19

Surgery Partners (SGRY) Stock Could Be 19% Undervalued As Growth And Debt Concerns Build

Recent commentary on Surgery Partners (SGRY) has focused on slowing sales volume growth, softer revenue growth expectations, and ongoing high debt levels. This combination appears to be affecting sentiment toward the stock. See our latest analysis for Surgery Partners. At a share price of $14.55, Surgery Partners has seen a 30 day share price return of 7.86% and a 90 day share price return of 23.31%. However, the 1 year total shareholder return is down 24.61%, pointing to some recent momentum...
Narrative Update Jun 15

SGRY: Reset Expectations And Steady Guidance Will Shape Future Multiple Potential

Analysts cut the fair value estimate for Surgery Partners stock by $4 to $14, reflecting updated assumptions around revenue growth, profit margins, the discount rate, and a lower future P/E multiple, despite recent mixed price target moves at Jefferies. Analyst Commentary Recent research shows mixed views on Surgery Partners, with some analysts adjusting price targets in both directions over a short period.

Recent updates

No updates